Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
24
pubmed:dateCreated
1998-1-7
pubmed:abstractText
Catabolic processing of the amyloid precursor protein (APP) is subject to regulatory control by protein kinases. We hypothesized that this regulation involves sequential activation of the enzymes mitogen-activated protein kinase kinase (MEK) and extracellular signal-regulated protein kinase (ERK). In the present investigation, we provide evidence that MEK is critically involved in regulating APP processing by both nerve growth factor and phorbol esters. Western blot analysis of the soluble N-terminal APP derivative APPs demonstrated that the synthetic MEK inhibitor PD 98059 antagonized nerve growth factor stimulation of both APPs production and ERK activation in PC12 cells. Moreover, PD 98059 inhibited phorbol ester stimulation of APPs production and activation of ERK in both human embryonic kidney cells and cortical neurons. Furthermore, overexpression of a kinase-inactive MEK mutant inhibited phorbol ester stimulation of APP secretion and activation of ERK in human embryonic kidney cell lines. Most important, PD 98059 antagonized phorbol ester-mediated inhibition of Abeta secretion from cells overexpressing human APP695 carrying the "Swedish mutation." Taken together, these data indicate that MEK and ERK may be critically involved in protein kinase C and nerve growth factor regulation of APP processing. The mitogen-activated protein kinase cascade may provide a novel target for altering catabolic processing of APP.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0270-6474
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
9415-22
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:9390997-Alzheimer Disease, pubmed-meshheading:9390997-Amyloid beta-Peptides, pubmed-meshheading:9390997-Amyloid beta-Protein Precursor, pubmed-meshheading:9390997-Animals, pubmed-meshheading:9390997-Calcium-Calmodulin-Dependent Protein Kinases, pubmed-meshheading:9390997-Carcinogens, pubmed-meshheading:9390997-Cells, Cultured, pubmed-meshheading:9390997-Cerebral Cortex, pubmed-meshheading:9390997-Enzyme Inhibitors, pubmed-meshheading:9390997-Female, pubmed-meshheading:9390997-Flavonoids, pubmed-meshheading:9390997-Humans, pubmed-meshheading:9390997-Kidney, pubmed-meshheading:9390997-Neurons, pubmed-meshheading:9390997-PC12 Cells, pubmed-meshheading:9390997-Phorbol Esters, pubmed-meshheading:9390997-Pregnancy, pubmed-meshheading:9390997-Protein Kinase C, pubmed-meshheading:9390997-Rats, pubmed-meshheading:9390997-Rats, Sprague-Dawley, pubmed-meshheading:9390997-Receptors, Nerve Growth Factor, pubmed-meshheading:9390997-Signal Transduction
pubmed:year
1997
pubmed:articleTitle
Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway.
pubmed:affiliation
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't